Efficacy of subcutaneous sumatriptan in postcraniotomy pain and opioid consumption
Postoperative single-dose subcutaneous sumatriptan following elective craniotomy may reduce pain scores and opioid requirements. Additional studies are needed to better understand nuanced differences in opioid modulation and optimal patient selection.
Authors
- Julia Herbst
- Nicholas Panos (ORCID: https://orcid.org/0000-0002-9868-699X)
- Dominick Richards
- Josha Woodward
- Bradley Kolb (ORCID: https://orcid.org/0000-0002-9417-7047)
- Sepehr Sani (ORCID: https://orcid.org/0000-0002-1737-5269)
- Lacin Koro
- Samuel Meza
- Ryan Kelly (ORCID: https://orcid.org/0000-0001-7546-1176)
- Lorenzo Muñoz
- Stephan A. Munich
- Aashka Patel
Institutions
- Rush University Medical Center (US)
Publication Details
- Journal
- Journal of neurosurgery
- Published
- 2024-08-01
- DOI
- https://doi.org/10.3171/2024.5.jns232827
- Citations
- 1
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39